21.77
Fulgent Genetics Inc stock is traded at $21.77, with a volume of 190.51K.
It is up +1.75% in the last 24 hours and up +16.85% over the past month.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
See More
Previous Close:
$21.39
Open:
$21.6
24h Volume:
190.51K
Relative Volume:
0.70
Market Cap:
$666.36M
Revenue:
$290.71M
Net Income/Loss:
$-163.43M
P/E Ratio:
-3.9726
EPS:
-5.48
Net Cash Flow:
$11.70M
1W Performance:
+2.40%
1M Performance:
+16.85%
6M Performance:
+32.26%
1Y Performance:
-5.55%
Fulgent Genetics Inc Stock (FLGT) Company Profile
Name
Fulgent Genetics Inc
Sector
Industry
Phone
626-350-0537
Address
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
FLGT
Fulgent Genetics Inc
|
21.77 | 658.71M | 290.71M | -163.43M | 11.70M | -5.48 |
![]()
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
![]()
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
![]()
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
![]()
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-05-25 | Upgrade | UBS | Neutral → Buy |
Dec-07-23 | Initiated | UBS | Neutral |
Dec-08-22 | Downgrade | Piper Sandler | Overweight → Neutral |
Nov-18-22 | Initiated | Raymond James | Outperform |
Aug-25-22 | Initiated | Credit Suisse | Outperform |
Feb-04-22 | Resumed | Piper Sandler | Overweight |
Aug-05-21 | Resumed | Credit Suisse | Underperform |
Jan-08-21 | Downgrade | Credit Suisse | Neutral → Underperform |
Nov-24-20 | Downgrade | BTIG Research | Buy → Neutral |
Aug-20-20 | Initiated | Oppenheimer | Outperform |
May-29-20 | Initiated | BTIG Research | Buy |
Nov-05-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
Mar-01-18 | Downgrade | Piper Jaffray | Overweight → Neutral |
Nov-07-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
View All
Fulgent Genetics Inc Stock (FLGT) Latest News
Momentum Traders Eye Fulgent Genetics Inc. for Quick Bounce2025 Breakouts & Breakdowns & Short-Term Trading Opportunity Alerts - mustnews.co.kr
Published on: 2025-08-20 20:27:21 - newsyoung.net
Fulgent Genetics Inc. Included in Top Momentum Scan2025 Major Catalysts & Risk Controlled Stock Pick Alerts - thegnnews.com
Can you recover from losses in Fulgent Genetics Inc.July 2025 Pullbacks & Daily Market Momentum Tracking - Newser
Published on: 2025-08-20 07:15:51 - classian.co.kr
Is this a good reentry point in Fulgent Genetics Inc.Product Launch & Fast Entry Momentum Alerts - Newser
Smart tools for monitoring Fulgent Genetics Inc.’s price actionGold Moves & Technical Pattern Recognition Alerts - Newser
What technical models suggest about Fulgent Genetics Inc.’s comebackSwing Trade & Reliable Intraday Trade Alerts - Newser
Will earnings trigger a reversal in Fulgent Genetics Inc.July 2025 EndofMonth & Comprehensive Market Scan Insights - Newser
Will Fulgent Genetics Inc. see short term momentumTrade Analysis Summary & Daily Profit Focused Stock Screening - Newser
Has Fulgent Genetics Inc. found a price floorJuly 2025 Price Swings & Expert Curated Trade Setups - Newser
Deutsche Bank AG Has $4.56 Million Holdings in Fulgent Genetics, Inc. $FLGT - MarketBeat
Live market analysis of Fulgent Genetics Inc.Jobs Report & Free Technical Pattern Based Buy Signals - Newser
Fulgent Genetics, Inc. $FLGT Shares Purchased by Connor Clark & Lunn Investment Management Ltd. - MarketBeat
What earnings revisions data tells us about Fulgent Genetics Inc.Wall Street Watch & Growth-Oriented Investment Plans - Newser
Using economic indicators to assess Fulgent Genetics Inc. potentialJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
Tools to assess Fulgent Genetics Inc.’s risk profileQuarterly Trade Review & Risk Controlled Daily Plans - Newser
Why Fulgent Genetics Stock Was Crushing It on Friday - MSN
How Fulgent Genetics Inc. stock performs during market volatilityJuly 2025 Earnings & Risk Adjusted Buy and Sell Alerts - Newser
Fulgent Genetics Inc. Sees Spike in Bullish Option FlowStock Surge & Weekly High Potential Alerts - metal.it
Using data tools to time your Fulgent Genetics Inc. exitAnalyst Upgrade & Verified Swing Trading Watchlists - Newser
Fulgent Genetics Inc. Stock Performance After Earnings: Historical InsightsEarnings Growth Summary & Long-Term Safe Investment Plans - Newser
Using data models to predict Fulgent Genetics Inc. stock movementMarket Trend Summary & Detailed Earnings Play Alerts - Newser
What institutional flow reveals about Fulgent Genetics Inc.2025 Volatility Report & Low Drawdown Trading Techniques - Newser
XTX Topco Ltd Invests $324,000 in Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Can Fulgent Genetics Inc. maintain sales growthInsider Selling & Consistent Profit Trade Alerts - newsyoung.net
Published on: 2025-08-15 02:58:56 - thegnnews.com
Is Fulgent Genetics Inc. in Accumulation Phase Now2025 Earnings Surprises & AI Forecasted Entry/Exit Points - sundaytimes.kr
Fulgent Genetics Inc. Recovery Likely Here’s What Data ShowsROI Boosting Trade Opportunity Calendar Published - beatles.ru
What moving averages say about Fulgent Genetics Inc.ROI Focused Setup With Drawdown Analysis - Newser
Fulgent Genetics (NASDAQ:FLGT) Trading Up 9.3%Should You Buy? - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded to "Buy" at UBS Group - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) PT Set at $21.00 by Piper Sandler - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Trading Down 3.4% Following Analyst Downgrade - MarketBeat
Fulgent Reports Second Quarter 2025 Financial Results - The Globe and Mail
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price In Tune With Revenues - 富途牛牛
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Is On The Mark - simplywall.st
Fulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings Guidance - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Issues Earnings Results - MarketBeat
UBS Upgrades Fulgent Genetics to Buy From Neutral, Adjusts Price Target to $30 From $20 - MarketScreener
Fulgent Genetics stock rating upgraded to Buy at UBS on growth potential - Investing.com Canada
Detecting price anomalies in Fulgent Genetics Inc. with AIEntry Zone Forecast for Momentum Trading - Newser
Fulgent Genetics lifts 2025 revenue outlook to $320M and narrows EPS loss guidance while advancing clinical pipeline - MSN
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Earnings Beat - MarketBeat
Fulgent Genetics Inc Stock (FLGT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Fulgent Genetics Inc Stock (FLGT) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Xie Jian | President and COO |
Jun 02 '25 |
Sale |
20.29 |
1,135 |
23,030 |
371,496 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):